Stifel Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Stifel Financial’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,286	Closed	-$491K	–	3555
2021 Q4	$491K	Sell	5,286 -42	-0.8%	-$2.77K	﹤0.01%	2599
2021 Q3	$317K	Buy	5,328 +604	+13%	+$35.7K	﹤0.01%	2869
2021 Q2	$323K	Buy	4,724 +14	+0.3%	+$913	﹤0.01%	2856
2021 Q1	$327K	Buy	+4,710	New	+$362K	﹤0.01%	2734
2020 Q4	–	Sell	-3,159	Closed	-$236K	–	3149
2020 Q3	$236K	Sell	3,159 -2,544	-45%	-$170K	﹤0.01%	2534
2020 Q2	$359K	Buy	+5,703	New	+$314K	﹤0.01%	2236

Stifel Financial's ARNA Position: Q1 2022 in Review

Stifel Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 5,286 shares — an estimated $491K sold.

Stifel Financial first reported a position in ARNA in Q2 2020 and held it in 6 quarters. The position peaked at $491K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Stifel Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Stifel Financial sold 5,286 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $491K.
Stifel Financial first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 6 quarters.
Stifel Financial's Arena Pharmaceuticals Inc position peaked at $491K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Stifel Financial's 13F filing for Q1 2022, filed 13 May 2022.